On May 7, 2020 Varian (NYSE: VAR) and the National University Cancer Institute, Singapore (NCIS), reported that are partnering to expand access to cancer solutions in Singapore in the fight against cancer (Press release, Varian Medical Systems, MAY 7, 2020, View Source [SID1234557329]). In 2018, 26,164 cases of cancer were diagnosed in Singapore, and it is expected to more than double to 57,319 cases over the next 20 years .1
Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:
Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing
Schedule Your 30 min Free Demo!
Two Varian VitalBeam medical linear accelerators, together with an Edge radiosurgery system with HyperArc technology, will be installed at NCIS, thereby expanding radiation therapy treatment options for cancer patients in Singapore.
Dr Francis Ho, head of the Department of Radiation Oncology at NCIS said: "We are proud to continue bringing in innovative therapy treatments, such as HyperArc, to help treat patients with cancer. We are committed to providing quality patient care to the people in Singapore. With this technology, we hope to reduce inefficiencies in plan creation and treatment delivery, leading to reduced treatment times for patients."
Kenneth Tan, president, Varian Asia Pacific said: "With an ever-rising number of patients being diagnosed with cancer and an increasingly aging population, it is now more important than ever to help patients and clinicians in Singapore in the fight against cancer. Through this partnership with the National University Cancer Institute, Singapore, and by bringing in high-quality radiation therapy combined with connected cancer care solutions, we are working towards our vision of living in a world without fear of cancer."
HyperArc technology is designed to automate and simplify sophisticated treatments such as stereotactic radiosurgery (SRS) and make them available to more cancer patients around the world. VitalBeam offers high-quality, high-throughput radiation therapy, which enables healthcare professionals to expand clinical capabilities and serve more patients with advanced treatment technology over time.